Article Data

  • Views 217
  • Dowloads 131

Original Research

Open Access

60Cobalt vs. linear accelerator in the treatment of locally advanced cervix carcinoma: a comparison of survival and recurrence patterns

  • K. Holcomb1,*,
  • N. Gabbur1
  • T. Tucker1
  • R. P. Matthews1
  • Y. C. Lee1
  • O. Abolafia1

1Division of Gynecologic Oncology, Department(!{ Obstetrics and Gynecology, Kings County Hospital and State University of New York-Health Science Center at Brooklyn, New York, USA

DOI: 10.12892/ejgo20010116 Vol.22,Issue 1,January 2001 pp.16-19

Published: 10 January 2001

*Corresponding Author(s): K. Holcomb E-mail:

Abstract

Objective: To compare the survival and recurrence patterns of patients with locally advanced cervical carcinoma treated with 60cobalt radiotherapy units and linear accelerators.

Methods: Two hundred and forty-eight patients with cervical carcinoma stages IIB-IVA who were treated with primary irradiation between the years 1985 and 1988 comprised the study group. The median survival of patients treated with 60cobalt units and linear accelerators was calculated using the method of Kaplan and Meier and compared using the log-rank test. Recurrence patterns were compared using chi-square analysis; p < .05 was considered significant for all tests.

Results: One hundred and ninety-five patients were treated with 60cobalt units (Group 1) and 53 patients were treated with a linear accelerator (Group 2). Group 1 and 2 were similar with regard to mean age and weight, stage distribution, and mean dose to point A. The rate of recurrence was comparable between Group 1 and 2 (65.6% vs. 64.2%) and no significant difference was found in overall survival between the groups (20 months vs. 21 months. p = 81). There was a trend toward increasing pelvic recurrence in Group 1 (50.8%) compared to Group 2 (35.8%, p = .08).

Conclusions: 60Cobalt units and linear accelerators offer comparable rates of overall survival in patients with locally advanced cervix carcinoma.

Keywords

Cervical carcinoma; 6°Cobalt; Linear Accelerator; Survival

Cite and Share

K. Holcomb,N. Gabbur,T. Tucker,R. P. Matthews,Y. C. Lee,O. Abolafia. 60Cobalt vs. linear accelerator in the treatment of locally advanced cervix carcinoma: a comparison of survival and recurrence patterns. European Journal of Gynaecological Oncology. 2001. 22(1);16-19.

References

[1] Wingo P.A., Tong T., Bolden S.: "Cancer Statistics". C. A. Cancer J. Clin., I 995, 45, 8.

[2] Karzrnark C. J., Nunan C. S., Tanabe E.: "Medical electron acccIerators". New York, McGraw-Hill, 1993.

[3] Karzmark C. J., Pering N. C.: "Electron linear accelerators for radiation therapy: history, principles, and contemporary developments". Phys. Med. Biol., 1973, 18, 321.

[4] Perez C. A., Purdy J. A., Korba A., Powers W. E.: "High-energy X-ray beams in the management of head and neck and pelvic cancers". In: Kramer S., ed. "High Energy Photons and Electrans". New York,J ohn Wiley,1976, 215.

[5] Allt W. E. C.: "Supervoltage radiation treatment in advanced cancer of the uterine cervix". Canad Med. Ass. J., 1969, 100, 792.

[6] Hanks G. E., Diamond J. J., Kramer S.: "The need for complex technology in radiation oncology. Correlation of facility characte ristics and structure with outcome". Cancer, 1985 May 1, 55 (Suppl. 9), 2198.

[7] Kaplan E. L., Meier P.: "Nonparametric estimation from mcomplete obserrvations". J. Amer. Statist. Assoc., 1958, 53, 457.

[8] Montana G. S., Hanlon A. L., Brickner T. J., Owen J. B., Hanks G. E., Ling C. C., Komaki R. et al.: "Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys". Int. J. Radial. Biol. Phys., 1995, Jul. 30, 32 (5), 1481.

[9] Bush R. F.: "Malignancies of the Ovary, Uterus, and Cervix" London, Edward Arnold, 1979.

[10] Johns E. H.:'The Physics of Radiology". (4th Ed山on) Spring fieId, Illinois, Charles C. Thomas Publisher, 183, 714.

[11] Hreshchyshyn M.,A ron B.,B oronow R.,F ranklin E.W. 3 d, Shingleton H. M., Blessing J. A.: "Hydroxyurea or placebo combined with radiation to treat stage IIB and IV cervical cancer confined to the pelvis". Int. J. Radial. Oncol. Biol. Phys.,1985, 5 ,317.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top